Can You Have PCOS With Regular Periods? Ovulatory PCOS Explained
9 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
Yes. Rotterdam criteria let androgen excess plus polycystic ovaries satisfy a PCOS diagnosis alone, with no cycle-length requirement. This pattern — “ovulatory PCOS,” or phenotype C — shows up in roughly 14% of PCOS diagnosed in clinics and up to a third found in general population screening. Regular bleeding is not the same as confirmed ovulation.
First, the name
In May 2026 a global consensus of more than 50 organisations renamed PCOS polyendocrine metabolic ovarian syndrome, or PMOS, in The Lancet. That change does not touch the arithmetic below. This article uses “PCOS” because that is still what shows up in search and on referral letters.
The arithmetic: Rotterdam does not require irregular cycles at all
Rotterdam’s two-of-three rule, kept by the current 2023 international guideline, allows androgen excess plus polycystic ovarian morphology to satisfy a diagnosis with cycles left entirely out of the equation. That is exactly how someone with a reliable 28-day cycle ends up with a PCOS diagnosis — her third feature is doing the work her cycle length never needed to. It is also why two people can sit across the same clinician in the same week, both leave with a PCOS diagnosis, and describe completely different menstrual histories to each other afterward — the criteria were built to allow that, not to produce a single uniform presentation.
| Phenotype | Features present | Cycles | Found in unselected screening |
|---|---|---|---|
| A | Androgen excess + anovulation + polycystic ovaries | Irregular | 19% (13–27%) |
| B | Androgen excess + anovulation, normal ovaries | Irregular | 25% (15–37%) |
| C — regular cycles | Androgen excess + polycystic ovaries, ovulation not disrupted | Regular | 34% (25–46%) |
| D | Anovulation + polycystic ovaries, no androgen excess | Irregular | 19% (14–25%) |
Phenotype C is the direct answer to the question in this page’s title, and in unselected population screening it is the single largest of the four groups. A pooled analysis of nearly 13,800 patients across 41 studies found phenotype C in 14% of women diagnosed through specialist referral, and in 34% of women found through unselected screening — more than double, because referral clinics are seeing the people whose irregular cycles sent them looking for answers, while regularly cycling phenotype C often never gets referred at all.
How many periods a year actually counts as “irregular”
The current guideline defines irregular with an actual number, not an impression: fewer than eight cycles a year, or any single cycle shorter than 21 days or longer than 35 days, for someone more than three years past her first period (full thresholds by age band are here). Eight or more cycles a year, each falling inside that 21-to-35-day window, is what “regular” means in the guideline’s own terms — not a subjective sense that periods “come when they’re supposed to.” A 28-to-32-day cycle that shows up ten or more times a year clears that bar comfortably, which is exactly the profile phenotype C describes.
For scale, a meta-analysis pooling 19 trials found oligo-anovulation on its own — cycle irregularity without either of the other two Rotterdam features present — in 15% of women studied (95% CI 12–18%). Irregularity alone is common enough that it does not automatically mean PCOS either; the same two-of-three arithmetic that allows regular cycles into a diagnosis also keeps irregular cycles alone out of one.
Regular bleeding is not the same as confirmed ovulation
A cycle can look completely regular on a calendar and still not be ovulatory. A prospective study of 259 healthy women who self-reported regular periods, followed for one or two full cycles, found that hormone-based algorithms classified 5.5% to 12.8% of those cycles as anovulatory — rising to 3.4% to 18.6% when algorithms relied on urinary LH alone, the kind of signal an over-the-counter ovulation predictor kit reads.
The direct check is a mid-luteal serum progesterone — drawn roughly seven days before the next period is expected, adjusted for actual cycle length rather than a fixed “day 21” that only applies to a 28-day cycle. For a 34-day cycle, that means testing closer to day 27, not day 21; testing too early on a longer cycle is a common reason a genuinely ovulatory cycle reads as falsely low. A result consistent with ovulation supports the phenotype C picture. A result that isn’t reframes the case as anovulatory after all, which moves it toward phenotype A instead and can change what gets discussed about fertility.
| Method | What it measures | Limitation in PCOS specifically |
|---|---|---|
| Calendar regularity | Whether bleeding arrives on a predictable schedule | A proxy at best — anovulatory cycles can still bleed on schedule |
| Urinary LH ovulation kits | The mid-cycle LH surge | Baseline LH runs high in PCOS, which can trigger a false or prolonged positive regardless of ovulation |
| Basal body temperature | The post-ovulatory temperature rise | Confirms ovulation only in hindsight, and requires daily consistency to read |
| Mid-luteal serum progesterone | The hormone produced after ovulation actually occurs | Most direct option; needs correct timing against real cycle length |
Urinary LH kits are the least reliable option in PCOS specifically, because baseline LH already runs high before ovulation is anywhere near happening, which is exactly why a positive result on one of those kits can mean less in PCOS than it does for someone without the condition.
Which phenotype you may be sitting in
If cycles arrive on a predictable, evidence-based “regular” schedule, and androgen excess and polycystic ovarian morphology are both documented, that is phenotype C — regular-cycle, ovulatory-appearing PCOS, real under Rotterdam and AE-PCOS criteria even though it produces none of the missed-period symptom that usually prompts someone to seek a diagnosis in the first place. Under the original 1990 NIH definition, this same presentation would not have been called PCOS at all, which is worth knowing if an earlier evaluation, years ago, concluded exactly that. If the ovaries look ordinary instead, and the irregular-cycle feature is what’s missing, that is the mirror-image case covered on can you have PCOS without cysts. And if the whole picture doesn’t cleanly resemble either — same symptoms, different underlying driver — the adrenal condition covered in non-classic CAH vs PCOS is worth ruling out before settling on either label.
Why phenotype C often gets diagnosed later, or missed entirely
Missed or unpredictable periods are what send most people looking for a PCOS work-up in the first place, and phenotype C never produces that trigger. Instead, the presenting complaint is usually acne, hirsutism scored on the Ferriman-Gallwey scale, or hair thinning — symptoms that get treated cosmetically, one at a time, for years before anyone connects them to a single underlying cause. How long a PCOS diagnosis normally takes already runs over two years on average across every phenotype combined; a presentation with no menstrual complaint to prompt the referral in the first place is a plausible reason phenotype C sits at the longer end of that range. Naming the two features that actually apply — androgen excess and polycystic ovarian morphology — at the first appointment, rather than waiting for a missed period that phenotype C was never going to produce, is what closes that gap. A specific list of questions to bring to that appointment helps make the case directly.
When regular periods mean something else, not “PCOS you just haven’t noticed”
This reasoning has a real limit. If cycles are genuinely regular, mid-luteal progesterone confirms ovulation, and androgens and ovarian appearance are both normal, none of the three Rotterdam features are actually present — that is not phenotype C, and pursuing a PCOS diagnosis on the strength of acne or weight alone is not supported by the criteria. Other explanations for those symptoms — including causes entirely unrelated to reproductive hormones — deserve their own work-up rather than a default PCOS label attached because the symptoms felt familiar. A normal androgen panel in particular should be taken seriously as a negative finding, not retested repeatedly on the assumption that PCOS must be hiding somewhere in the numbers.
What to ask for at your next appointment
Ask which two of the three Rotterdam features are actually documented in the chart, since regular cycles do not exclude PCOS the way they were once assumed to. If androgen excess and polycystic ovarian morphology are both already confirmed, a normal cycle history changes nothing about the diagnosis under current criteria — it just means fertility questions should be asked directly rather than inferred from calendar regularity. If pregnancy planning is on the horizon at all, that conversation is worth having before it becomes urgent, since conception with PCOS is its own subject with its own realistic numbers, separate from whether a diagnosis technically applies. For the full breakdown of how these thresholds are set, the diagnostic criteria and the four phenotypes cover it from the beginning, and how the whole work-up fits together, test by test picks up from there.
Common questions
What is ovulatory PCOS?
Ovulatory PCOS, or phenotype C, describes androgen excess plus polycystic-appearing ovaries in someone whose cycles remain regular and largely ovulatory. It is recognised under Rotterdam and AE-PCOS criteria and is the most common phenotype found in unselected population screening.How many periods a year counts as PCOS?
The 2023 international guideline defines irregular as fewer than eight cycles a year, or any cycle shorter than 21 days or longer than 35 days, more than three years after a first period. Eight or more cycles a year inside that window counts as regular.Can you have PCOS with regular periods but not be ovulating?
Yes, and the reverse is also true for people without PCOS — a study of healthy, regularly cycling women found 5.5% to 12.8% of cycles were anovulatory by hormone testing. Regularity is a proxy for ovulation, not confirmation of it; a mid-luteal progesterone test checks directly.Is phenotype C PCOS as serious as the other phenotypes?
It carries the same androgen and ovarian findings as phenotype A, just without the cycle disruption. Metabolic risk in phenotype C has been studied less than in phenotypes involving anovulation, which is a real gap rather than reassurance that it can be ignored.Why would a doctor say I don't have PCOS because my periods are regular?
That reasoning reflects the original 1990 NIH criteria, which required anovulation. Rotterdam, adopted in 2003 and still current, does not require irregular cycles at all if androgen excess and polycystic ovaries are both present.
- HOMA-IR Score for PCOS: What It Means and Why There's No One CutoffA HOMA-IR score for PCOS has no universal cutoff — published thresholds range 2.0–2.9 depending on lab and assay. What the number is, its limits, and better tests.
- PCOS Pelvic Ultrasound Results Explained, Number by NumberReading a PCOS pelvic ultrasound report: what follicle count, ovarian volume, and endometrial thickness numbers mean, and why a scan alone can't diagnose PCOS.
- Can PCOS Be Misdiagnosed? Two Errors, Different HarmsPCOS can be misdiagnosed both ways: six look-alike conditions get missed, and one of them worsens on the standard PCOS advice to eat less and move more.
- Polycystic Ovaries But Not PCOS: The Scan Finding Isn't the DiagnosisA polycystic-looking scan is not a PCOS diagnosis. About a third of ovulating women have it. Why the Rotterdam rule still requires two of three criteria.
Sources
- 1.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004.
- 2.Teede HJ, Tay CT, Laven JJE, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023.
- 3.Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016.
- 4.Lizneva D, Kirubakaran R, Mykhalchenko K, et al. Phenotypes and Body Mass in Women With Polycystic Ovary Syndrome Identified in Referral Versus Unselected Populations: Systematic Review and Meta-Analysis. Fertil Steril. 2016.
- 5.Lynch KE, Mumford SL, Schliep KC, Whitcomb BW, et al. Assessment of Anovulation in Eumenorrheic Women: Comparison of Ovulation Detection Algorithms. Fertil Steril. 2014.
- 6.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.